Updated:
Ambler Brook
Ambler Brook was established in 2024 by partners whose prior roles included positions at Candescent Partners, Solamere Capital and Thomas H. Lee Partners.
Ambler Brook
Ambler Brook was established in 2024 by partners whose prior roles included positions at Candescent Partners, Solamere Capital and Thomas H. Lee Partners. The firm invests capital originated by entrepreneurs and executives in healthcare and technology services. The strategy centers on growth equity in Healthcare Services, InsurTech, RegTech and Workflow Automation. Positions take the form of direct co-investments and SPVs. Confirmed activity includes a Q4 2024 co-investment in Tower MSA Partners, LLC with Eagle Private Capital and Resolute Capital Partners. Geographic coverage is limited to North America. Technology emphasis includes AI/ML and Enterprise Software. Team size and total deployment remain undisclosed. The firm maintains membership in Axial since 2024 for M&A sourcing. Max D. serves as Vice President, Value Creation. The structure separates the multi-family office mandate from prior private-equity affiliations, allowing independent deployment without fund commitments to external managers.
General information
Firm type
Multi Family Office
Year founded
2024
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Principals
Max D.
Vice President, Value Creation
Sector focus
Frequently asked questions
Who runs investment decisions at Ambler Brook?
Founding partners with prior experience at Thomas H. Lee Partners, Solamere Capital and Candescent Partners lead decisions. Max D. holds the role of Vice President, Value Creation.
How does Ambler Brook source proprietary deal flow?
The firm uses its Axial membership, established in 2024, to connect with M&A advisors. Prior relationships from Candescent Partners, Solamere Capital and Thomas H. Lee Partners provide additional channels.
Does Ambler Brook participate in fund commitments or only direct deals?
Activity centers on direct co-investments and SPVs. The Q4 2024 Tower MSA Partners transaction included minority equity alongside debt from Eagle Private Capital and Resolute Capital Partners.
What investment stages does Ambler Brook typically target?
The firm focuses on growth equity in lower middle-market companies with under $15M EBITDA.
Where does the underlying wealth come from?
Capital originates from entrepreneurs and executives in healthcare and technology services.
What is Ambler Brook's known posture on co-investments alongside external GPs?
The firm has executed co-investments with debt and equity partners such as Eagle Private Capital and Resolute Capital Partners in 2024.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: